D.E. Shaw & Co’s Genesco GCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.27M | Sell |
285,126
-79,201
| -22% | -$2.28M | 0.01% | 1798 |
|
|
2025
Q4 | $9.02M | Buy |
364,327
+18,650
| +5% | +$535K | ﹤0.01% | 1853 |
|
|
2025
Q3 | $10M | Sell |
345,677
-120,602
| -26% | -$3.32M | 0.01% | 1686 |
|
|
2025
Q2 | $9.18M | Buy |
466,279
+182,699
| +64% | +$3.82M | 0.01% | 1558 |
|
|
2025
Q1 | $6.02M | Sell |
283,580
-128,783
| -31% | -$4.48M | 0.01% | 1754 |
|
|
2024
Q4 | $17.6M | Sell |
412,363
-124,229
| -23% | -$4.08M | 0.01% | 1105 |
|
|
2024
Q3 | $14.6M | Sell |
536,592
-7,111
| -1% | -$197K | 0.01% | 1184 |
|
|
2024
Q2 | $14.1M | Buy |
543,703
+20,171
| +4% | +$528K | 0.01% | 1118 |
|
|
2024
Q1 | $14.7M | Buy |
523,532
+7,050
| +1% | +$204K | 0.01% | 1114 |
|
|
2023
Q4 | $18.2M | Sell |
516,482
-11,360
| -2% | -$349K | 0.02% | 993 |
|
|
2023
Q3 | $16.3M | Buy |
527,842
+143,106
| +37% | +$4.06M | 0.02% | 971 |
|
|
2023
Q2 | $9.63M | Buy |
384,736
+273,949
| +247% | +$7.93M | 0.01% | 1369 |
|
|
2023
Q1 | $4.09M | Buy |
110,787
+35,223
| +47% | +$1.54M | ﹤0.01% | 2112 |
|
|
2022
Q4 | $3.48M | Buy |
75,564
+43,508
| +136% | +$1.97M | ﹤0.01% | 2432 |
|
|
2022
Q3 | $1.26M | Buy |
32,056
+23,435
| +272% | +$1.25M | ﹤0.01% | 3417 |
|
|
2022
Q2 | $430K | Buy |
8,621
+5,321
| +161% | +$319K | ﹤0.01% | 4182 |
|
|
2022
Q1 | $210K | Buy |
+3,300
| New | +$215K | ﹤0.01% | 4839 |
|
|
2021
Q1 | – | Sell |
-8,312
| Closed | -$250K | – | 4200 |
|
|
2020
Q4 | $250K | Sell |
8,312
-39,071
| -82% | -$998K | ﹤0.01% | 3661 |
|
|
2020
Q3 | $1.02M | Buy |
47,383
+12,991
| +38% | +$254K | ﹤0.01% | 2840 |
|
|
2020
Q2 | $745K | Buy |
34,392
+19,689
| +134% | +$363K | ﹤0.01% | 3128 |
|
|
2020
Q1 | $196K | Sell |
14,703
-65,892
| -82% | -$2.22M | ﹤0.01% | 3653 |
|
|
2019
Q4 | $3.86M | Sell |
80,595
-65,480
| -45% | -$2.72M | ﹤0.01% | 1937 |
|
|
2019
Q3 | $5.85M | Sell |
146,075
-43,579
| -23% | -$1.68M | 0.01% | 1532 |
|
|
2019
Q2 | $8.02M | Buy |
189,654
+123,191
| +185% | +$5.45M | 0.01% | 1258 |
|
|
2019
Q1 | $3.03M | Buy |
66,463
+34,088
| +105% | +$1.56M | ﹤0.01% | 1866 |
|
|
2018
Q4 | $1.43M | Buy |
32,375
+19,354
| +149% | +$836K | ﹤0.01% | 2416 |
|
|
2018
Q3 | $613K | Sell |
13,021
-17,691
| -58% | -$772K | ﹤0.01% | 2993 |
|
|
2018
Q2 | $1.22M | Sell |
30,712
-67,437
| -69% | -$2.87M | ﹤0.01% | 2570 |
|
|
2018
Q1 | $3.98M | Sell |
98,149
-26,319
| -21% | -$977K | 0.01% | 1560 |
|
|
2017
Q4 | $4.04M | Sell |
124,468
-163,961
| -57% | -$4.51M | 0.01% | 1634 |
|
|
2017
Q3 | $7.67M | Buy |
288,429
+162,347
| +129% | +$4.59M | 0.01% | 1099 |
|
|
2017
Q2 | $4.27M | Buy |
126,082
+19,868
| +19% | +$887K | 0.01% | 1459 |
|
|
2017
Q1 | $5.89M | Buy |
+106,214
| New | +$6.33M | 0.01% | 1176 |
|
|
2015
Q4 | – | Sell |
-30,803
| Closed | -$1.76M | – | 3863 |
|
|
2015
Q3 | $1.76M | Buy |
+30,803
| New | +$1.91M | ﹤0.01% | 2194 |
|
|
2013
Q4 | – | Sell |
-16,440
| Closed | -$1.08M | – | 4536 |
|
|
2013
Q3 | $1.08M | Sell |
16,440
-10,101
| -38% | -$691K | ﹤0.01% | 2979 |
|
|
2013
Q2 | $1.78M | Buy |
+26,541
| New | +$1.71M | ﹤0.01% | 2236 |
|
Other funds holding GCO
VCM
F1I
KCM
D.E. Shaw & Co's GCO Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Genesco (GCO) stake by 22% in Q1 2026, selling an estimated $2.28M and leaving 285,126 shares worth $8.27M. The position accounts for 0.01% of the portfolio, ranked #1798.
D.E. Shaw & Co first reported a position in GCO in Q2 2013 and has held it in 36 quarters since. The position peaked at $18.2M in Q4 2023. 129 funds tracked by Wall St. Rank hold GCO as of Q1 2026.
- D.E. Shaw & Co held 285,126 shares of Genesco worth $8.27M as of Q1 2026.
- D.E. Shaw & Co sold 79,201 Genesco shares in Q1 2026, an estimated $2.28M.
- Genesco made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1798 holding.
- D.E. Shaw & Co first reported a position in Genesco in Q2 2013 and has held it in 36 quarters since.
- D.E. Shaw & Co's Genesco position peaked at $18.2M in Q4 2023.
- 129 funds tracked by Wall St. Rank held Genesco as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.